Objective To evaluate the relation between adherence to drug therapy, including placebo,
and mortality. Design Meta-analysis of observational studies. Data sources Electronic …

… Dean T Eurich, research associate1, … The data for Eurich 2005 were pooled from the
metformin monotherapy group and combination therapy group (pooled test for heterogeneity P=0.70…

Due to a vulnerable blood supply of the bile ducts, biliary complications are a major source
of morbidity after liver transplantation (LT). Manifestation is either seen at the anastomotic …

OBJECTIVE—Metformin is considered contraindicated in patients with heart failure because
of concerns over lactic acidosis, despite increasing evidence of potential benefit. The aim of …

… ▸ Les RDC les plus fréquemment rapportées par les patients (c.-à-d. la toux, le mal de
dos et les douleurs abdominales) étaient essentiellement des conditions symptomatiques. …

Background— There is an ongoing controversy regarding the safety and effectiveness of
metformin in the setting of heart failure (HF). Therefore, we undertook a systematic review of the …

Objectives To determine whether statins reduce mortality or need for admission to intensive
care in patients admitted to hospital with community acquired pneumonia; and to assess …

Background: Over the past 30 years, the relation between use of sulfonylureas to treat type
2 diabetes and the risk of cardiovascular events has been vigorously debated. The purpose …

OBJECTIVE Diabetes and heart failure commonly coexist, and prior studies have suggested
better outcomes with metformin than other antidiabetic agents. We designed this study to …

People with type 2 diabetes form a heterogeneous group. Consequently, treatment regimens
and therapeutic targets should be individualized. The treatment of type 2 diabetes involves …